Travelers Companies (NYSE: TRV) exec exercises options and sells 16,313 shares

Q: What stock option exercises did TRV executive Mojgan M Lefebvre report?

Mojgan M Lefebvre exercised stock options for 9,213 shares at $132.5800 and 7,100 shares at $139.8300 . Both option exercises occurred on July 21, 2026, converting the options into an equal number of Travelers (TRV) common shares.

Q: How many TRV shares did Mojgan M Lefebvre sell on July 21, 2026?

On July 21, 2026, Mojgan M Lefebvre sold a total of 16,313 Travelers (TRV) common shares. The sales consisted of 9,213 shares from one option exercise and 7,100 shares from another option exercise, all reported as direct ownership transactions.

Q: At what prices were Mojgan M Lefebvre’s TRV shares sold?

Lefebvre sold 9,213 TRV shares at a weighted-average price of $368.3547 , with individual prices from $368.16 to $368.57 , and sold another 7,100 shares at $368.4050 . All trades were reported as open market or private transactions.

Q: Were Mojgan M Lefebvre’s TRV trades made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not affirmatively marked , and no footnote describes a Rule 10b5-1 trading plan. The reported July 21, 2026 transactions for Travelers (TRV) therefore are not identified as being executed pursuant to a pre-arranged trading plan.

Q: What types of securities were involved in Mojgan M Lefebvre’s TRV Form 4?

The Form 4 reports derivative Stock Options (Right to Buy) and the underlying Common Stock of Travelers (TRV). Options were exercised into common shares, which were then sold in open market or private transactions on the same date.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Mojgan M Lefebvre, EVP & Chief Tech & Ops Officer of Travelers Companies, Inc., exercised stock options for 9,213 shares at $132.5800 and 7,100 shares at $139.8300 on July 21, 2026, receiving common stock and selling 9,213 shares at a weighted-average $368.3547 (for prices from $368.16 to $368.57) and 7,100 shares at $368.4050, for total sales of 16,313 shares.

Insider Trade Summary

Exercise and Sale: 16,313 shares ($3.80M approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Lefebvre Mojgan M

Role EVP & Chief Tech & Ops Officer

Sold 16,313 shs ($6.01M)

Approx. gross sale proceeds $6.01M

Approx. exercise cost $2.21M

Approx. pre-tax spread $3.80M

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	9,213	$0.00	$0.00
Exercise	Stock Options (Right to Buy)	7,100	$0.00	$0.00
Exercise	Common Stock	9,213	$132.58	$1.22M
Sale	Common Stock ^F1	9,213	$368.3547	$3.39M
Exercise	Common Stock	7,100	$139.83	$993K
Sale	Common Stock	7,100	$368.405	$2.62M

Holdings After Transaction: Stock Options (Right to Buy) — 21,214 shares (Direct); Common Stock — 0 shares (Direct)

Footnotes (1)

F1. Represents the weighted average sales price for price increments ranging from $368.16 to $368.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Options Exercised: 9,213 shares Options Exercised: 7,100 shares Shares Sold (block 1): 9,213 shares at $368.3547 +3 more

6 metrics

Options Exercised 9,213 shares Stock options exercised at $132.5800 on July 21, 2026

Options Exercised 7,100 shares Stock options exercised at $139.8300 on July 21, 2026

Shares Sold (block 1) 9,213 shares at $368.3547 Weighted-average sale price with trades from $368.16 to $368.57

Shares Sold (block 2) 7,100 shares at $368.4050 Common stock sale on July 21, 2026

Total Shares Sold 16,313 shares Aggregate TRV common shares sold in reported transactions

Option Exercise Prices $132.5800 and $139.8300 Exercise or conversion prices for stock options into common stock

Key Terms

Stock Options (Right to Buy), weighted average sales price, Exercise or conversion of derivative security

3 terms

Stock Options (Right to Buy) financial

"security_title lists "Stock Options (Right to Buy)" for derivative entries"

weighted average sales price financial

"Footnote explains a "weighted average sales price" for trades between $368.16 and $368.57"

Exercise or conversion of derivative security financial

"transaction_code_description states "Exercise or conversion of derivative security" for code M"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/23/2026 - 04:06 PM Accepted by SEC EDGAR 07/23/2026 - 04:06 PM

FAQ

What stock option exercises did TRV executive Mojgan M Lefebvre report?

Mojgan M Lefebvre exercised stock options for 9,213 shares at $132.5800 and 7,100 shares at $139.8300. Both option exercises occurred on July 21, 2026, converting the options into an equal number of Travelers (TRV) common shares.

How many TRV shares did Mojgan M Lefebvre sell on July 21, 2026?

On July 21, 2026, Mojgan M Lefebvre sold a total of 16,313 Travelers (TRV) common shares. The sales consisted of 9,213 shares from one option exercise and 7,100 shares from another option exercise, all reported as direct ownership transactions.

At what prices were Mojgan M Lefebvre’s TRV shares sold?

Lefebvre sold 9,213 TRV shares at a weighted-average price of $368.3547, with individual prices from $368.16 to $368.57, and sold another 7,100 shares at $368.4050. All trades were reported as open market or private transactions.

Were Mojgan M Lefebvre’s TRV trades made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not affirmatively marked, and no footnote describes a Rule 10b5-1 trading plan. The reported July 21, 2026 transactions for Travelers (TRV) therefore are not identified as being executed pursuant to a pre-arranged trading plan.

What types of securities were involved in Mojgan M Lefebvre’s TRV Form 4?

The Form 4 reports derivative Stock Options (Right to Buy) and the underlying Common Stock of Travelers (TRV). Options were exercised into common shares, which were then sold in open market or private transactions on the same date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lefebvre Mojgan M

(Last)

(First)

(Middle)

THE TRAVELERS COMPANIES, INC.

385 WASHINGTON STREET

(Street)

ST. PAUL

MINNESOTA

55102

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TRAVELERS COMPANIES, INC. [ TRV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & Chief Tech & Ops Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/21/2026		M		9,213	A	$132.58	9,213	D
Common Stock	07/21/2026		S		9,213	D	$368.3547⁽¹⁾	0	D
Common Stock	07/21/2026		M		7,100	A	$139.83	7,100	D
Common Stock	07/21/2026		S		7,100	D	$368.405	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to Buy)	$132.58	07/21/2026		M			9,213	02/04/2023	02/04/2030	Common Stock	9,213	$0	0	D
Stock Options (Right to Buy)	$139.83	07/21/2026		M			7,100	02/02/2024	02/02/2031	Common Stock	7,100	$0	21,214	D

Explanation of Responses:

1. Represents the weighted average sales price for price increments ranging from $368.16 to $368.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

	/s/ Wendy C. Skjerven, by power of attorney	07/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR